Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus ropivacaine for paravertebral analgesia after thoracic surgery
ChiCTR2400087560Phase 4Recruiting
- Sponsor
- Beijing Chest Hospital
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine and ropivacaine in acute postoperative pain (2 arms), sponsored by Beijing Chest Hospital. Primary endpoint: Numeric Rating Scale pain score at 24 hours after surgery. Started Feb 2024; status: recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2400087560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087560.